Your session is about to expire
← Back to Search
ATI-V Program for Preventing Adolescent Vaping
Study Summary
This trial will test the effectiveness of a school-based intervention to reduce adolescent vaping. The intervention will train 8th-9th grade student peer leaders to deliver school-wide vaping prevention campaigns with ongoing adult mentoring.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I understand I cannot be excluded based on my race, gender, age, or abilities.I am currently an 8th grader at the study school.You do not speak English.
- Group 1: Delayed Above the Influence-Vaping Intervention
- Group 2: Immediate Above the Influence-Vaping Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could I potentially partake in this research initiative?
"Candidates who wish to join this clinical trial must be between 12 and 18 years old, have a strong social network, and meet the 3840 participant quota."
Is this trial accepting additional participants?
"According to clinicaltrials.gov, the medical trial in question has ceased recruitment efforts since its last update on May 9th 2022. Nevertheless, there are still 13 other studies actively seeking participants at this time."
Does this trial cater to individuals over the age of 35?
"This trial is open to all children between 12-18 years of age."
Share this study with friends
Copy Link
Messenger